Research, Measurement, Assessment, Design, and Analysis (RMADA) 2 Indefinite Delivery, Indefinite Quantity (IDIQ) Contract Extension

Closed Special Notice Posted

Solicitation number
RMADA2
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Baltimore, Maryland, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Centers for Medicare & Medicaid Services (CMS) has issued a Special Notice announcing its intent to extend the Research, Measurement, Assessment, Design, and Analysis (RMADA) 2 Indefinite Delivery, Indefinite Quantity (IDIQ) contract for up to 12 months beyond its current July 31, 2025 expiration date. This sole source extension affects 20 current contract holders including major firms such as Abt Associates, Acumen, Booz Allen Hamilton, Deloitte, IBM, Mathematica, and Westat. The extension is necessary because while CMS is currently recompeting the contract under solicitation 75FCMC25RJ018 for the RMADA3 IDIQ replacement, potential delays in the competitive process could leave CMS without a contract vehicle to support critical operations. The RMADA2 IDIQ serves as CMS's primary mechanism for supporting model programs under the Patient Protection and Affordable Care Act, focusing on analytic support and technical assistance for research, payment, and service delivery models.

The primary purpose of this extension is to maintain continuity of critical services while the competitive follow-on RMADA3 IDIQ is being awarded, preventing operational disruption and negative impacts to mission readiness. Interested parties who believe they can provide the required services may submit a 10-page capability statement to Jason Vollmer via email by 12:00 PM EST on July 10, 2025. CMS will evaluate these responses to determine whether a competitive procurement process should be initiated instead of proceeding with the sole source extension, though the final decision remains at the government's sole discretion. The contract falls under NAICS code 541720 for Research and Development in Social Sciences and Humanities and PSC code AN42 for Health R&D Services. Once the RMADA3 IDIQ ordering period begins, no new government requirements will be placed against the extended RMADA2 contract, ensuring a smooth transition to the new contract vehicle.

Notice text

The Centers for Medicare & Medicaid Services (CMS) intends to extend the Period of Performance for the Research, Measurement, Assessment, Design, and Analysis (RMADA) 2 Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicle.

The RMADA2 IDIQ is currently being recompeted under solicitation 75FCMC25RJ018 utilizing full and open procedures; however, the current RMADA2 IDIQ ordering period ends July 31, 2025. As a result of the potential for delays in the recompete of the RMADA3 IDIQ, a determination has been made that there is a continued need for the current RMADA2 IDIQ, past July 31, 2025. This is a temporary action to maintain critical services while the competitive follow-on IDIQ is awarded. It is the Government’s intent to modify the terms of the current RMADA2 IDIQ so that once the ordering period for RMADA3 IDIQ begins, no new Government requirements will be ordered against the current NEC IDIQ, regardless of its extended Period of Performance.

The extension will allow the Government to continue placing orders under the existing IDIQ contract beyond July 31, 2025, for a period not to exceed twelve (12) months. The proposed sole source extension will provide CMS the ability for the RMADA2 IDIQ to continue to serve as CMS' primary mechanism to support CMS’ model programs.  By extending the RMADA2 IDIQ, CMS avoids allowing the IDIQ to expire before the replacement is in place, which would disrupt operations and negatively impact mission readiness.

Please see the attached notice for additional information.

Files

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity